Additional markers previously described in intratumoral Tregs, including CD39, HLA-DR, and IRF4, were overexpressed by BC Tregs compared to Tconv and Teff, indicating consistency of these phenotypes among the different patients (Fig. 4d). Here, IRF4 is linked to breast cancer.